Evaluation of cancer testis antigen (CT10, PRAME) and MHC I expression in high grade urothelial carcinoma of the bladder

Immunotherapeutic strategies are increasingly used in the treatment of a number of malignancies including high grade urothelial carcinoma (HGUC) of the bladder. Because of this, detailed and accurate assessment of the tumour immune microenvironment is paramount. In this study, we aimed to correlate...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodgson, Anjelica, Jungbluth, Achim A., Katabi, Nora, Xu, Bin, Downes, Michelle R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596305/
https://www.ncbi.nlm.nih.gov/pubmed/31485721
http://dx.doi.org/10.1007/s00428-019-02661-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596305/
https://www.ncbi.nlm.nih.gov/pubmed/31485721
http://dx.doi.org/10.1007/s00428-019-02661-2

Ejemplares similares